N
Google TrendMATTHEW STONE SR (200+) — Adult victims, suspected shooter ID'd in Erie mass shooting
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:matthew stone sr200+selma blair2000+al-nassr vs neftchi fergana5000+samantha busch500+crimson rescued mountain lion cub500+peggy flanagan200+sean combs10000+boeing 747500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "FDA issues priority vouch" (30 stories)

Top Headline Story

Drug companies, patient groups urge FDA to pause commissioner’s voucher program
Lead StorySTATgeneral
Jun 4

Drug companies, patient groups urge FDA to pause commissioner’s voucher program

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxNRUl1eGVWMGRqeUxHbzlOTEdHQmhIUjl0YVFVRVRrTW9ZLU9URVJvTkEwbVp3OFlaQ015NXA3QjRaQmdKeWJmV2ZZTjZjMXVVNnIwb3RkM1NiT1JuNGxSb3JHeFBmYXEwWVdWQndGSVRrLW5qNC1ITTkxMTJfcTBVbE41RDQtTFdjWnBqb1NjUkxFRzAzYWdPM3ZkQVVlbHdyZllwODJ4WkhBSnc?oc=5" target="_blank">Drug companies, patient groups urge FDA to pause commissioner’s voucher program</a>  <font color="#6f6f6f">STAT</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+14m ago

matthew stone sr

Adult victims, suspected shooter ID'd in Erie mass shooting

Filter stories
2000+34m ago

selma blair

Selma Blair Arrested, Attacks Flight Crew After Trying to Open Plane Door Mid-Air

Filter stories
5000+44m ago

al-nassr vs neftchi fergana

Al Nassr Asian Champions League clash in doubt over Riyadh security situation

Filter stories
500+44m ago

samantha busch

Kyle Busch’s Widow Samantha Calls His Death ‘Unfair’ After ‘Emotional’ Celebration for Beloved NASCAR Star

Filter stories

Search Results for "FDA issues priority vouch"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Critics call for National Priority Voucher program reform
Chemical & Engineering Newsgeneral

Critics call for National Priority Voucher program reform

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQcnNtVDN4ai1hUVI2dG5JakN4eXpaUndFakhXQ2FfXzFuNXI1QWU0S0RxcEdlZnZXYWJLNzhFN0x2ZlQ3X2I1bnRmbDJxVndqdVRZb3lUQlBvWFVqRUVjSW1tT1F4NnhOWUZ6M29EX0FNOVBMTGx5TmZ1cW1OWTNmemhZWlNENVZBMEFwM1hIQk00SXR2YmNHY2tOd0hja3dJQ01zM3RuaTJtaFJaSXZOTA?oc=5" target="_blank">Critics call for National Priority Voucher program reform</a>  <font color="#6f6f6f">Chemical & Engineering News</font>

Read Full StoryMore like this
FDA Policy Tracker 2026: FDA taps prior knowledge to expedite cell and gene therapy development
BioSpacegeneral

FDA Policy Tracker 2026: FDA taps prior knowledge to expedite cell and gene therapy development

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxOVExtVEdya3I4QUNjLUZHOVdFSnJhdHUyQUgzRDdPc2RtLUJiMkhCeFpFZ0w3Sm9ValpZRHdHNGRNZTFDeXlSVTI1YTFBUG1ZVlowSzFrSnBWclpTX2pDS1dFc05sNFpydnI2Tk44SGhpOHFFOGZ6RGwxeUY0X2lSSkZLN3Y5M29YeFN3UmpwNUFqX0tvUDQ1dA?oc=5" target="_blank">FDA Policy Tracker 2026: FDA taps prior knowledge to expedite cell and gene therapy development</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
At first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from experts
Fierce Biotechgeneral

At first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from experts

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNUlpDUTZBNFNXdUFNOVZnOGpzQTNxeE04RmN3MTZrYTdvVWZBVGxpU0ZLQkUyZlVhTEFrZld3bnRJY0pvNHNYdURVZXhoVmY4WVNSbHBabU5JaGdYcGVmNHFUXzNIaWN2OWlEd1B3X0tXRkQtc2Vmdmpic294RU00QzlURm9lSEFWOXRWTG03SVdnTUY3bm9zcVFINUwyVTNQb2FtZk1ZYlY?oc=5" target="_blank">At first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from experts</a>  <font color="#6f6f6f">Fierce Biotech</font>

Read Full StoryMore like this
Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona
Psychedelic Alphageneral

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPS1RYZk9FSS1uYUpBV3Rqa0s5cVVEd2V0NGpuR0JJZURvUVRrTTF1Q0g1emo4ZG1PT09VeUJYbnUtck0zMm5tTXFBMk50R0JkdjdhQWZrcjd6UVNxeW9GNzhSNGNkMHJVUUEzNXFaZU1waWZLRXdFQjFVTjZkMEhMUGEwWkpjWVpQSXBEeDNIekpYbm8xQ2t6RG4yNnlBU1U2cThqWDVIdEdYNGM?oc=5" target="_blank">Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona</a>  <font color="#6f6f6f">Psychedelic Alpha</font>

Read Full StoryMore like this
Congress Rallies to Extend Rare Pediatric Disease Priority Review Voucher Program
Akin Gump Strauss Hauer & Feld LLPgeneral

Congress Rallies to Extend Rare Pediatric Disease Priority Review Voucher Program

<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxOY1RxZ25rUHNQRV95elNfNWJWdkxhaEl6ZmFuQzZfSGFlS0licWtYVnNBZGt4aXlaSWtTeG5neDNJLWZCTmxYeWp6b0ZUUGU1a3N3VjZmUks3ckxtVFZHQzZBUlljODA5T3d2NFBXMUZIMno5S2NlM1dqbzB2ZXNkS3NaYWxWeTZhbUJsc01nV2kzRzBkcEtiZjRCRFFIUU5pYTU1QTQxaExfVGNtR0lkV3NyeW9IQmNtLVZrMzV1ajFoYURSX2R6eXRFa3E1NUZu?oc=5" target="_blank">Congress Rallies to Extend Rare Pediatric Disease Priority Review Voucher Program</a>  <font color="#6f6f6f">Akin Gump Strauss Hauer & Feld LLP</font>

Read Full StoryMore like this
Critics Raise Transparency Concerns Over FDA National Priority Voucher Program
Genome Webtech

Critics Raise Transparency Concerns Over FDA National Priority Voucher Program

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNcXR3UVhIQ2ZFQ0JhX1h0SnhDX3FsbVZrOGFpbzJoWHdoMGJxMWRRWEtnLUpLWHFvbDktNGpOaVlEclpQUzdUa0xzOGRoSE95RXppRVhueTF2WHI3MHNzYWVaQmFkRHZSTmptcDl3aElPWHplRnZwUTFrNk9sckQzWHVzSTVWdnM3OVA5aV9LemNxcVFiQ3JHajRZdHBaQW5HN1pwbGtBbkVIbW1kTDVmQm5GTWtuLXZIR0dj?oc=5" target="_blank">Critics Raise Transparency Concerns Over FDA National Priority Voucher Program</a>  <font color="#6f6f6f">Genome Web</font>

Read Full StoryMore like this
FDA issues priority vouchers for psychedelics developers Compass Pathways, Usona Institute, and Transcend Therapeutics
The Microdose | Substackgeneral

FDA issues priority vouchers for psychedelics developers Compass Pathways, Usona Institute, and Transcend Therapeutics

<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTFBIdDRhNTl2dTlyc2dpWms3Q1FyWEtjWmo1NEl3UjNicFpTZEQ2VVJPY1RaYjVwM2JJa09LTlZ0WDRlTWxXSkI3LWJGOWFCNnJ0bzRwZTNraWRraWY1RE1LQ3NvNkxGRTJ6TGVyNFI3S01XRFVsOURz?oc=5" target="_blank">FDA issues priority vouchers for psychedelics developers Compass Pathways, Usona Institute, and Transcend Therapeutics</a>  <font color="#6f6f6f">The Microdose | Substack</font>

Read Full StoryMore like this
FDA solicits feedback on controversial national priority voucher review pathway
Fierce Pharmageneral

FDA solicits feedback on controversial national priority voucher review pathway

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQcnFfMlJMMUFwSjRhQ3c0QzZ1WGthZHhZQWM2SHU5Q1ZneW11d0o3LW5GS3FtOTFIYl9nemFlUUMzck4wX1hqUzQ0bllmdVZIUlF1WXJKOUJ5R0dCWlM1cC1RbVZwQWt0MnRZV1lBWGxScDhkbnFyMFFMYVZWZmlNb0xVa2tFaVAwaGFrT0ZlSGlEVk4weWFCazU1NERZX2p3amttU2J4V2tJU2FxTFZnaHJn?oc=5" target="_blank">FDA solicits feedback on controversial national priority voucher review pathway</a>  <font color="#6f6f6f">Fierce Pharma</font>

Read Full StoryMore like this
FDA issues vouchers to 3 companies to help fast track review of potential psychedelic medications - ABC News
Breaking News, Latest News and Videosgeneral

FDA issues vouchers to 3 companies to help fast track review of potential psychedelic medications - ABC News

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxNd1JTNldyTks2OFJjQnZnZ1ZObWVTeWtLS2Rfa25ueFY1a2tNMnBpVi1vanhDZFJzLUp5WENsVS05YlZRNkhqVm1qbzBuS2piSmRKbzNaMnJZMkxHdk14dXFPYVlabkQxMDV6SG1IazJOaF9WcmljMFo0NnFqaUhEeDdrSzFkSkNBeWFzM0VMRU5qd3pSN0pPQURWTdIBoAFBVV95cUxNYUc2YkMtNnVoSzhGSXVaWk5xNHJMV09CTDFnQlFJMDBBd1otbkRzek9mcnlaY2dZTkhkUDhPU19zT1N5MUVYbjdVeThuZzdBNXduVEhqNFJpQWxXRzJEaWdJNUNfMzZLd3FBeDlEQjJkOFg5c0RYMHR4R2QxNk1tbTJMZE1pbWpzSDR3Qm5USFBnd3dLWEthSVNSTGtkVC0w?oc=5" target="_blank">FDA issues vouchers to 3 companies to help fast track review of potential psychedelic medications</a>  <font color="#6f6f6f">ABC News - Breaking News, Latest News and Videos</font>

Read Full StoryMore like this
Some drugmakers quietly concerned about legal risk with speedy FDA review program
Reutersgeneral

Some drugmakers quietly concerned about legal risk with speedy FDA review program

<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxPUXY1Um5nZ213N2pQZEhEUW1jc3pEcTJBREpjRjRQSFhreEdZT2lKdEUwZWFMdnJmUmtHRGtpdnlxWk4tN1hWX0l3VkVXS0pMcjZ2dm9ualRnT2dRRmRuRUJKcjJ6b0xhWkUwbV9hTEMwVmJuZl9DVC1waDdkN0Qwdk5Cc1lkOVlhSXByZFVZazZOSy03N1EyOUhPOWFJUm5IS3paZnoxcDJNSVZXdFNBc1o2akRrdnpCUkhuNlpaWndudXlH?oc=5" target="_blank">Some drugmakers quietly concerned about legal risk with speedy FDA review program</a>  <font color="#6f6f6f">Reuters</font>

Read Full StoryMore like this
FDA's new expedited drug program raises legal questions and concerns
PBStech

FDA's new expedited drug program raises legal questions and concerns

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxOMFdZVFMweUg5TU1pNXdhNE5UYk5GeG5nZE1PaWp5aG5kN1lWYXo2SVlYdno3SktuWlNTbnotcHNOS2xncERueGVxZFQtWHdiQTRDUk1qSmtLR3paS184YjhWMmk4YUdsZ3U3N3FoNHl5MG00UTdEbUhJS3ZfakRfdXRRd2tZTnRFbEJKc2lkRjRaZ0NjU0tJclBMN2FIWXBndm9lMzJn?oc=5" target="_blank">FDA's new expedited drug program raises legal questions and concerns</a>  <font color="#6f6f6f">PBS</font>

Read Full StoryMore like this
9 Months In, FDA’s New Priority Voucher Program Still Clouded With Uncertainty
BioSpacetech

9 Months In, FDA’s New Priority Voucher Program Still Clouded With Uncertainty

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNUGpjVGtETndwSTJhZ1h4VXdacDVydW1hd1VaQkVSWHZpa1BhUHR6eGRFMHNlX01nVU03TmJoX19Gc2w4THRBU1c1cTVWVDV6V1J3RTlTVl9iUC16NWNiVFpqNEdhWlE3OTFjU1Y0c2VtdWppRnNOYzlKbnFteFpZM0lsd01JenJ1UzRRRnBNeTAzS1FFWUJ6czk0TWpWcUpVcGtwaGx1S2s?oc=5" target="_blank">9 Months In, FDA’s New Priority Voucher Program Still Clouded With Uncertainty</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
FDA Commissioner Marty Makary tries to soothe staff concerns over voucher program
STATgeneral

FDA Commissioner Marty Makary tries to soothe staff concerns over voucher program

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQV0Y4TXhET1JYTm9uR0xwdTliak95X0duNnhPM28zUjdSWkxkNEFXbkRqZG1fd1IxU21lTG44cGRZcjdSMFhIc1NlRlFxMTRxX0NtbWZvNWZSaUp4UFg5aFBKTDRMQjNuNUZabVFuVjR3MTRSNDY5OEtEX240dlV6N3RMbmpVQl9LTHZMOElySEhoNEp0dFNmTzctR1BySlo4c180a1czZUpLUVFYaXh6b2Z3?oc=5" target="_blank">FDA Commissioner Marty Makary tries to soothe staff concerns over voucher program</a>  <font color="#6f6f6f">STAT</font>

Read Full StoryMore like this
EXCLUSIVE: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Reutersgeneral

EXCLUSIVE: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns

<a href="https://news.google.com/rss/articles/CBMi4gFBVV95cUxOQ2RMem15ZG4xVGs5a0R6Q3Vudm9GQkRlTmNvNzhaWUR3WUJtNm1fUkI2ZFY0cjlET0t6S3BwUzlqSnlQZW1OWG9LSjJmSm5MRnFwdWpoZEZGZGJhWWkyNzV2ekhsOWhkTlRGbE9FTWdsVHpZSURYX09jS1FYTXZSeFJKLVo1VlBTUUxnRDBkc0JwSW9YWFBreUI0N0gySWlXMTdUNkV4andrRWRpR3Y2emxvVWJmRGo1bW0wZ2dNV25EOWF0UU04dHRRNjhBYURkODBkdlFwRTJoUkNXTHRsTTh3?oc=5" target="_blank">EXCLUSIVE: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns</a>  <font color="#6f6f6f">Reuters</font>

Read Full StoryMore like this
Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay
BioSpacegeneral

Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNUWJmZGhyTE05TDI4WE1xTTVQNUFNTkRzSi1uY1Z1a2hvbllrOEhtSGYtUWJTZW5lNlJidnk0UlJHVTJqaDRPWHJlTTR4dHNoMmlqYV9qbldmV1N0dmRUeXBBZkhJM2dwdXlqcDNhZ09GdloxQTNSWDc4N1RVWjBIdzFPUXJpUFFOY2w2T2dHZkVYUWwxOWpn?oc=5" target="_blank">Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
FDA voucher program has become vehicle for political interference in drug review decisions, staffers say
STATgeneral

FDA voucher program has become vehicle for political interference in drug review decisions, staffers say

<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxOdDAzelpNLUN1Q0ZyQXFlbEt5aDZsa3MwNW0zSjZWSktIY2hIdkpFUnpSY3QyNk54V3BEQ1ZSRnlHTmpVWnVmUDNUVWtxeWxYMlZlUlFXV0NJdi1KTkQ0WklsZnozOGwwWWxsbXRmQmp4cHZyNVB2WVAwNEc4SklDeTAzRjdVQQ?oc=5" target="_blank">FDA voucher program has become vehicle for political interference in drug review decisions, staffers say</a>  <font color="#6f6f6f">STAT</font>

Read Full StoryMore like this
FDA’s new voucher program hints at broader policy agenda, making many ‘uncomfortable’
BioSpaceworld

FDA’s new voucher program hints at broader policy agenda, making many ‘uncomfortable’

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNZk14ZlRBeG1UZFNMR2lYQXNFRWlMbTJ3WE8xLTVMUHotdUhLMlFHOERnVDRhdzkzQkxsTTQwdVRMZURXRWRTUy10UEhPbXNRcHVIVFNyMlNuc0RJZVhlVHdJcWJxOUFjRXJHX2tMZGxsSnhEcHFEcjNJaWRtTmRzN3NUeWliRkdpSGh2UHVHTjRmazd3UTNNc1lsTzBfWnNRdVVReTBLU29Rb2VTM2xN?oc=5" target="_blank">FDA’s new voucher program hints at broader policy agenda, making many ‘uncomfortable’</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
Stakeholders want Makary’s voucher program paused, call for FDA independence
BioSpacegeneral

Stakeholders want Makary’s voucher program paused, call for FDA independence

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQVXIwaDBUSlRCYzJJUHo2a1NrbkZmblpCcXZ0QzZWX2F1S1R5azZVcHo2djRSSjc1UUctRmlTbmdfZjVNajQwdEVjWUgyZ210YmhOLS15NmhJWTJoVk9WUHRWQ3pSZm8zVVV2Qkx4N0tNemFnQThldDVnWTFfVU0yR1o4S2syRFhfTEY5YlN1bW9xZmRCWHk5clBlaDliYjI5Y0t0NDNVQQ?oc=5" target="_blank">Stakeholders want Makary’s voucher program paused, call for FDA independence</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
Disc’s FDA Rejection Raises Questions About Commissioner’s Vouchers
BioSpacetech

Disc’s FDA Rejection Raises Questions About Commissioner’s Vouchers

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxPcnZEWjZDc1hlVkFQN0JwcEVGUWNDTGZ2UGFDbWQxcmNyalVIZUZ5OHRSVnJBYnBXaWpBZ2RsWkF0Ulp2bnY2ZUZaSUctY1otdklzY25XbFpoc3ZOSlhoV1lkNFotSDdIckhwbW9SRktUUktjX0M4SFg2eHdyNkI2U3FLeTdocUIxbTEzRnVUMGdPbUlRV3hsdkRB?oc=5" target="_blank">Disc’s FDA Rejection Raises Questions About Commissioner’s Vouchers</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
What the FDA’s Priority Voucher Decision Means for Psychedelic Drug Development
Genetic Engineering and Biotechnology Newsgeneral

What the FDA’s Priority Voucher Decision Means for Psychedelic Drug Development

<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxOT1U5bnhhRDNKbVdTcVkwR2F0ZmhsUG1SQUI1dlF0aVNaay12V0o2QTg5NHd0U2FMS19WXzB5SlVFSHh6VjJpNGFCdHNtRVpSQkU4ZVowVXAyY1NYbkxoZldYYXVOeHlfMzI2U3drM0xBbk9xcVNtVERxeFktM2NJUXJWZjBtd2tFRlRRSVdrT1hxV3NSdTVrdHlxOTgyOXdFNGlGRnRVLXlJS3hUZEZZdTJ4RDV4YTFEd0tPUW9ZaVl1RzBfWlQ3SEJOQ3p6MVJUZlE?oc=5" target="_blank">What the FDA’s Priority Voucher Decision Means for Psychedelic Drug Development</a>  <font color="#6f6f6f">Genetic Engineering and Biotechnology News</font>

Read Full StoryMore like this
Trump executive order fast-tracks FDA review of psychedelic drugs for serious mental illness
Manufacturing Chemistgeneral

Trump executive order fast-tracks FDA review of psychedelic drugs for serious mental illness

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNWXZCR1duVEQzdVVFNTduQnl0Mi1DVm1hRUd2QzlXNXVpUzJLNGwxQzV6TWdJVkp5Q0lrYW1MV1BSZHZYZi1uZHkzU3VHSzg1S1lkOENjMWhlelljRE5XZy1wQmJPX0h5V0ZzdEl4TWlvVm1BeFNiVE1xazY4Z2UwWHBHdHAtanN0SlVpTTgtRjZPYXpfU1hN?oc=5" target="_blank">Trump executive order fast-tracks FDA review of psychedelic drugs for serious mental illness</a>  <font color="#6f6f6f">Manufacturing Chemist</font>

Read Full StoryMore like this
FDA 'Priority Voucher' Program Comes Under Congressional Scrutiny
MedPage Todayworld

FDA 'Priority Voucher' Program Comes Under Congressional Scrutiny

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE8tWFpveVRRejY3bFFJNUJmeWJwNlh3cTFFdGFrR25DTktpaXo0SmgxQnNsTUhaLWl1WFFwVmc1d2tReUl4UFlaZW5IVTRZb204Zm5helFkRWVFa2hhZVQzZnRTWXBQTWViQnZuQm93Z0NaSEE?oc=5" target="_blank">FDA 'Priority Voucher' Program Comes Under Congressional Scrutiny</a>  <font color="#6f6f6f">MedPage Today</font>

Read Full StoryMore like this
FDA issues speedy approval to J&J’s Tecvayli-Darzalex combo
BioPharma Divegeneral

FDA issues speedy approval to J&J’s Tecvayli-Darzalex combo

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxPTjA3TkZKSVVSLTdxU2RkRUFoeks0VUZTSjZ3LUxvWXNTUnUyT1VxWTJrRXc2UmNieEdzY00zTzhoclBROWJYd0trWlcwOFkyNFFVWWV1ZjZuZXQ0TU01cUJuNVNkalpJcUNDak1uZ2c5QTJmVWxfaVlNWUlZUHRXVTZZb0laX3BrQUJqQm5ZNjJ4eDZaM0h3VGZoekk5cXdleWJPdC05Tzc3aHIxbk02aVB1a1Fob1E?oc=5" target="_blank">FDA issues speedy approval to J&J’s Tecvayli-Darzalex combo</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
FDA review staff was excluded from voting on whether to approve first priority voucher drug
STATgeneral

FDA review staff was excluded from voting on whether to approve first priority voucher drug

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxOMnpUYm1aTU83UXptYlNCVGlUV3JyQlRFNEIzU285N0dBcVZTOUFnWERLNk83NXBsUTN3RDI4bk14ME9IX3dmSnJsbnp6Zzl4UjRLWHNsVDB4aWVrSE9OdllPSjV5UXRTQS1pU091djNrMVhZc0xjNVdoS3p1R3B5RFUxanhkOHFyeVllZy1YQ2FWblNRajJFUWw0OFVKdm5ucHVLYmhB?oc=5" target="_blank">FDA review staff was excluded from voting on whether to approve first priority voucher drug</a>  <font color="#6f6f6f">STAT</font>

Read Full StoryMore like this
FDA Continues to Expand National Priority Voucher Program
Pharmaceutical Executivegeneral

FDA Continues to Expand National Priority Voucher Program

<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxQUzcxQnllVElTaFMxQkJ2dWlESVN1TU9aQUJXN0h3ZXl3RThBREVrMno5Q05ENHM1Rkx2RkNVNWRMNGpGb0dVS2c3OUdNeWRwd2N5Zi14MGR1V1NoM2taV2xFRXVRYVhsZGpybGpzNzVHLXZDanFhX3lqRVJnYWc5eA?oc=5" target="_blank">FDA Continues to Expand National Priority Voucher Program</a>  <font color="#6f6f6f">Pharmaceutical Executive</font>

Read Full StoryMore like this
FDA rejects Disc's rare disease drug despite commissioner's voucher
Fierce Biotechgeneral

FDA rejects Disc's rare disease drug despite commissioner's voucher

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQLU5UNy1xeWpLTjQtZkNxZ0YwUFRUNmlFTEZ6U1V5TFJFenJuMFdKU05pMEhfWGQ3TDFVaVcxdEkyZ1Vuay1ycDVJNzNXblEzWWVoYnRFX3NZNnBVTmpoS1dubUF5ejlRYi1fZVRSLWxjZDZyNnB6ZWxCLXFoQ1RzeDRuVzhLcDhFZG95a0dpTklNeFpyVm5FQ0lqRlN4UVUybW44WUN3?oc=5" target="_blank">FDA rejects Disc's rare disease drug despite commissioner's voucher</a>  <font color="#6f6f6f">Fierce Biotech</font>

Read Full StoryMore like this
FDA Under Scrutiny: 4 Issues Facing Beleaguered Agency
Newsweekworld

FDA Under Scrutiny: 4 Issues Facing Beleaguered Agency

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxOby1uclZ2dmFKS2hEN1VDeDFQemFxcVN1bEZSU1p0OXVYMnN0TlU2X3h3bWRRcEk3VzFrZDZ2RzNJRmFJMlpEaUxFdFNFNk56elNoQk5MS3g1aHNOdlV2RE9SX3BYSmlhTTh0cUZtNHVybUdhTWFzYXBkZV82T3ZXbU5kOUkwT1M4NE1JaElha0c?oc=5" target="_blank">FDA Under Scrutiny: 4 Issues Facing Beleaguered Agency</a>  <font color="#6f6f6f">Newsweek</font>

Read Full StoryMore like this
FDA reveals 2nd round of 'national priority' voucher winners, including obesity giants Lilly and Novo
Fierce Biotechworld

FDA reveals 2nd round of 'national priority' voucher winners, including obesity giants Lilly and Novo

<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxPQ2ladU15VEl1RFdxRVpyVW5la1ZiY3l3aUNZekdpaUh2Nk01ekNta2dObG9PWmVXRTh3eENpTzBxYjd0ZkhHY01INjJObjV4eFBqa1VKczgzUk0wN0JmQ1g5Tk5qTnNXaVhIMDNJUXBxUHRkT3JhMTJQdC1IeHo2UXNYQlMwRWJxeF9lRExqWG1VSHFfWmR1MEZGaTltVl9ZTS1WWGxBWjBGcVItOVFQdWFBTFgzeEtSQmtySVNlbmcwUlFfekZV?oc=5" target="_blank">FDA reveals 2nd round of 'national priority' voucher winners, including obesity giants Lilly and Novo</a>  <font color="#6f6f6f">Fierce Biotech</font>

Read Full StoryMore like this
FDA Issues CRL to Disc Medicine for Eythropoietic Protoporphyria Treatment Bitopertin
Pharmaceutical Executivegeneral

FDA Issues CRL to Disc Medicine for Eythropoietic Protoporphyria Treatment Bitopertin

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNXzZRa1E4cDQ5aXdRQVZtTThlVU0xY3UtamdMV1ZJTmRiRnZSQ2FfTm1GSzNwWkNmejhKNTBaU1NFNG5nU0p5T3BnVEo0NXd6bEx4OUx5em4wSnVoOHdwa09zSENveDRpUmg0Q2RqM0w3RWxQeDJYcU1jSzdGWXo4SjdnZG93ZWh5N2NaMHNCSXE4dG1TQXRWSHZCX3drekZDa3ZSZQ?oc=5" target="_blank">FDA Issues CRL to Disc Medicine for Eythropoietic Protoporphyria Treatment Bitopertin</a>  <font color="#6f6f6f">Pharmaceutical Executive</font>

Read Full StoryMore like this
"FDA issues priority vouch" — Live Google News Trends & Headlines